Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer [PDF]
, 2007 Background Selective cyclooxygenase inhibitors may retard the progression of cancer, but they have enhanced thrombotic potential. We report on cardiovascular adverse events in patients receiving rofecoxib to reduce rates of recurrence of colorectal ...
Christopher C. McConkey +23 more
core +1 more source
Four-extremity blood pressure measurements according to major adverse cardiovascular events.
, 2021 Four-extremity blood pressure measurements according to major adverse cardiovascular events.
Joo-Hee Zo (721373) +6 more
core +1 more source
Antithrombotic therapy in peripheral arterial disease
Frontiers in Cardiovascular Medicine, 2022 BackgroundPatients with peripheral arterial disease (PAD) are at increased risk for major adverse cardiovascular events (MACE) such as cardiovascular death, myocardial infarction, and stroke as well as major adverse limb events (MALE) such as amputation ...
Christine Espinola-Klein +5 more
doaj +1 more source
Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
European Heart Journal Open, 2023 Abstract Aims Prospective studies show that only a minority of plaques with higher risk features develop future major adverse cardiovascular events (MACE), indicating the need for more predictive markers.
Gu, Sophie Z +10 more
openaire +2 more sources
Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
International Journal of Cardiology: Heart & Vasculature, 2022 Background: New-onset atrial fibrillation (AF) during COVID-19 infection is associated with worse cardiovascular outcomes and mortality, with new-onset AF being associated with worse clinical outcomes than recurrent AF. However, it is not known whether a
Michael J. Cutler +10 more
doaj +1 more source
Multivariate Cox analysis for major adverse cardiovascular events.
, 2015 Multivariate Cox analysis for major adverse cardiovascular events.
Jiaojiao Xu (813939) +11 more
core +1 more source
Association of periodontal disease with the risk of major adverse cardiovascular events.
, 2023 Association of periodontal disease with the risk of major adverse cardiovascular events.
Chunjuan Liao (16955321) +4 more
core +1 more source
Association of Fasting Blood Sugar to High-density Lipoprotein Ratio with Short Term Outcome in Patients of Acute Coronary Syndrome: A Cohort Study [PDF]
Journal of Clinical and Diagnostic ResearchIntroduction: Acute Coronary Syndrome (ACS), which includes Unstable Angina (UA) and Myocardial Infarction (MI) both ST elevated and non-ST-elevated (STEMI and NSTEMI), is a critical condition with high morbidity and mortality, emphasising the ...
Donisri Morampudi +3 more
doaj +1 more source
Treatment effect estimates for major adverse cardiovascular events (MACE).
, 2019 Treatment effect estimates for major adverse cardiovascular events (MACE).
Théodora Bejan-Angoulvant (2147893) +15 more
core +1 more source
Alexandria Journal of MedicineObjectives Patients with ST-segment elevation myocardial infarction (STEMI) and high thrombus burden are at increased risk of distal embolization and adverse outcomes. The best interventional approach remains uncertain.
Hanan A. A. Samour +5 more
doaj +1 more source